Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Subst Abuse Treat. 2019 Jan 26;100:18–28. doi: 10.1016/j.jsat.2019.01.019

Table 2:

Number of responses and votes received for whether or not to initiate medication assisted therapy (MAT, Question 1) and evaluating individual MAT strategy preferences (Question 2)*

Topic Total number of responses generated N=220 (% of total responses) Number of highly-ranked responses N=90 (% of highly-ranked responses) Total number of votes cast N=716 (% of total number of votes) No. of votes cast for highly-ranked items N=400 (% of votes cast for highly-ranked items)
Q1, What are considerations for starting any medication treatment at all? 116 (53%) 24 (27%) 116 (16%) 83 (21%)
What are the positive and negative features of methadone? 45 (20%) 23 (26%) 141 (20%) 109 (27%)
What are the positive and negative features of buprenorphine-naloxone sublingual? 23 (10%) 17 (9%) 315 (44%) 74 (19%)
What are the positive and negative features of injected naltrexone? 28 (13%) 21 (23%) 110 (15%) 102 (26%)
What are the positive and negative features of implantable buprenorphine? 7 (3%) 5 (6%) 33 (5%) 32 (8%)
*

Each individual was able to cast 3 votes for every question (distributed among 1–3 responses). High-ranking responses were 5 responses receiving most votes per question, with at least 2 votes (if tied, more than 5 were included),